Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Fariborz Kamal currently holds 4,347 shares of 4D Molecular Therapeutics Inc. (FDMT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Fariborz Kamal has been a net buyer of FDMT stock. They have purchased $100.0K and sold $0 worth of shares.
Fariborz Kamal's most recent insider trade was on Dec 15, 2020, when they purchased 4,347 shares at $23.00 per share.
Fariborz Kamal serves as Executive at 4D Molecular Therapeutics Inc. (FDMT). They have executed 1 insider transactions totaling $100.0K over their tenure at the company.
Fariborz Kamal holds the position of Executive at 4D Molecular Therapeutics Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 6 years and currently hold a stake valued at $0.
Fariborz Kamal has shown a buying trading pattern, with $100.0K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Fariborz Kamal was on Dec 15, 2020, when they purchased $100.0K worth of FDMT shares. This transaction involved 4,347 shares at $23.00 per share.
Fariborz Kamal currently owns 4,347 shares of 4D Molecular Therapeutics Inc. (FDMT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Fariborz Kamal's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Fariborz Kamal has 1 Form 4 filings on record as an insider at 4D Molecular Therapeutics Inc..
Set alerts for Fariborz Kamal and 40,000+ other insiders.